Literature DB >> 21328000

Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in Okinawa, southern Japan.

Zeyi Deng1, Masahiro Hasegawa, Sen Matayoshi, Asanori Kiyuna, Yukashi Yamashita, Hiroyuki Maeda, Mikio Suzuki.   

Abstract

Previous studies from Okinawa, a subtropical island in southern Japan, demonstrated a higher prevalence of human papillomavirus (HPV) in oral carcinoma and a higher incidence of oral and pharyngeal carcinoma than those for mainland Japan. The present study aims to investigate epidemiologic and clinical features of HPV in head and neck squamous cell carcinoma (HNSCC) in Okinawa. A total of 150 DNA samples from 150 Okinawan patients with head and neck squamous cell carcinoma (HNSCC) were screened for HPV sequences by PCR using three consensus primer sets, and HPV types were determined by direct sequencing. The samples were consisted of 46 cases from the hypopharynx, 44 from the oropharynx, 16 from the larynx, 25 from the oral cavity, 10 from the maxillary sinus, and 9 from the nasopharynx. HPV DNA was detected in 45 (30.0%) HNSCCs, and HPV-16 was identified in 86.7% of positive specimens. The highest prevalence of the HPV sequence was found in oropharyngeal carcinomas (50.0%), especially in tonsillar cancer (63.6%). Multivariate analysis showed that oropharyngeal carcinoma (P = 0.002; OR = 5.34; 95% CI = 1.83-15.58), oral cavity carcinoma (P = 0.012; OR = 4.94; 95% CI = 1.43-17.10), and histological poor differentiation (P = 0.011; OR = 4.25; 95% CI = 1.39-13.04) each independently increased the prevalence of HPV infection. The present study reveals that patients with HNSCC, e.g., oropharyngeal and oral cavity carcinomas, in Okinawa have relatively high HPV-16 positive rates and low HPV-18 positive rates comparing with mainland Japan.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21328000     DOI: 10.1007/s00405-011-1515-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.

Authors:  A M de Roda Husman; J M Walboomers; A J van den Brule; C J Meijer; P J Snijders
Journal:  J Gen Virol       Date:  1995-04       Impact factor: 3.891

2.  Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.

Authors:  J P Klussmann; S J Weissenborn; U Wieland; V Dries; J Kolligs; M Jungehuelsing; H E Eckel; H P Dienes; H J Pfister; P G Fuchs
Journal:  Cancer       Date:  2001-12-01       Impact factor: 6.860

3.  Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma.

Authors:  H Mineta; T Ogino; H M Amano; Y Ohkawa; K Araki; S Takebayashi; K Miura
Journal:  Anticancer Res       Date:  1998 Nov-Dec       Impact factor: 2.480

4.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.

Authors:  J Mork; A K Lie; E Glattre; G Hallmans; E Jellum; P Koskela; B Møller; E Pukkala; J T Schiller; L Youngman; M Lehtinen; J Dillner
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

7.  Comparative study of oral squamous cell carcinoma in Okinawa, Southern Japan and Sapporo in Hokkaido, Northern Japan; with special reference to human papillomavirus and Epstein-Barr virus infection.

Authors:  K Tsuhako; I Nakazato; J Miyagi; T Iwamasa; A Arasaki; H Hiratsuka; H Sunakawa; G Kohama; T Abo
Journal:  J Oral Pathol Med       Date:  2000-02       Impact factor: 4.253

8.  Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue.

Authors:  Renwei Chen; Peter Sehr; Tim Waterboer; Ilmo Leivo; Michael Pawlita; Antti Vaheri; Leena-Maija Aaltonen
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Detection and typing of human papillomaviruses present in fixed and stained archival cervical smears by a consensus polymerase chain reaction and direct sequence analysis allow the identification of a broad spectrum of human papillomavirus types.

Authors:  H L Smits; L M Tieben; S P Tjong-A-Hung; M F Jebbink; R P Minnaar; C L Jansen; J ter Schegget
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

10.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

View more
  14 in total

Review 1.  Is there a higher prevalence of human papillomavirus infection in Chinese laryngeal cancer patients? A systematic review and meta-analysis.

Authors:  Chunlin Zhang; Zeyi Deng; Yuehong Chen; Mikio Suzuki; Minqiang Xie
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-26       Impact factor: 2.503

2.  Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma.

Authors:  Mitsuhiko Nakahira; Naoko Saito; Hiroshi Yamaguchi; Kiyomi Kuba; Masashi Sugasawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-24       Impact factor: 2.503

Review 3.  Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.

Authors:  Aarti Bhatia; Barbara Burtness
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

4.  Tumor microenvironment contributes to Epstein-Barr virus anti-nuclear antigen-1 antibody production in nasopharyngeal carcinoma.

Authors:  Ping Ai; Zhiping Li; Yong Jiang; Changping Song; Lin Zhang; Huaizhong Hu; Tao Wang
Journal:  Oncol Lett       Date:  2017-06-22       Impact factor: 2.967

Review 5.  Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review.

Authors:  Tatyana Isayeva; Yufeng Li; Daniel Maswahu; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2012-07-03

6.  Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients.

Authors:  Camille Ragin; Jeffrey C Liu; Gieira Jones; Olubunmi Shoyele; Bukola Sowunmi; Rachel Kennett; Harry J M Groen; Denise Gibbs; Elizabeth Blackman; Michael Esan; Margaret S Brandwein; Karthik Devarajan; Francesco Bussu; Rebecca Chernock; Chih-Yen Chien; Marc A Cohen; El-Mofty Samir; Suzuki Mikio; Gypsyamber D'Souza; Pauline Funchain; Charis Eng; Susanne M Gollin; Angela Hong; Yuh-S Jung; Maximilian Krüger; James Lewis; Patrizia Morbini; Santo Landolfo; Massimo Rittà; Jos Straetmans; Krisztina Szarka; Ruth Tachezy; Francis P Worden; Deborah Nelson; Samuel Gathere; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2016-12-26       Impact factor: 4.944

7.  Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.

Authors:  Tetsuya Shimabuku; Ayumi Tamanaha; Bunta Kitamura; Yasuka Tanabe; Natsumi Tawata; Fukino Ikehara; Kazunari Arakaki; Takao Kinjo
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 8.  Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review.

Authors:  Pauline M W van Kempen; Rob Noorlag; Weibel W Braunius; Inge Stegeman; Stefan M Willems; Wilko Grolman
Journal:  Epigenetics       Date:  2013-10-29       Impact factor: 4.528

9.  Effects of Methylation Status of CpG Sites within the HPV16 Long Control Region on HPV16-Positive Head and Neck Cancer Cells.

Authors:  Chunlin Zhang; Zeyi Deng; Xiaoli Pan; Takayuki Uehara; Mikio Suzuki; Minqiang Xie
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

10.  A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.

Authors:  Zeyi Deng; Masahiro Hasegawa; Kazuo Aoki; Sen Matayoshi; Asanori Kiyuna; Yukashi Yamashita; Takayuki Uehara; Shinya Agena; Hiroyuki Maeda; Minqiang Xie; Mikio Suzuki
Journal:  Int J Oncol       Date:  2014-05-12       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.